Search results for: 'cell ad gene therapy cold chain'

This research service analyzes the market for cell-based assays within the United States. This market was divided into three segments, covering cell growth-associated assays, cell death-associated assays, and functional cell assays. Each segment of this service provides an overview, analysis of products available, revenue forecasts, and market sh...

Antibody-drug conjugates (ADCs) are therapies that target cancer cells with antigen-specific antibodies and highly toxic payloads. ADCs are currently generating interest among drug developers, contract manufacturing companies, regulatory agencies, and other stakeholders. The rise in the number of drug approvals has also sparked interest in further ...

Greener energy sources are being favored globally due to the emissions of large amounts of hazardous particles from the conventional power sources. Fuel cells, wind turbines, and solar panels are amongst the energy sources being looked towards offering cleaner, efficient power to the end users. With the growing initiatives by the Indian Government,...

17 Jul 2017  |  North America  |  Market Research

US Oncology Diagnostics Market, Forecast to 2021

Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection

Infographics

×

Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights into recent technological developments for molecular marker detection, drug delivery, cancer immunotherapies and radiopharmaceuticals. The TOE also comprises analysis of innovations across cell and gene therapy, antibody and gene editing platfo...

This report provides a summarial view of US select cell culture markets in respect to sera, media, and media supplements and growth factors. It includes analyses of market size, competition, revenues, trends, market specific drivers and restraints, current and expected challenges, and strategic recommendations.

The global biopharma patient access market is undergoing a structural shift as specialty medicines make downstream commercialization more complex and strategically important. Patient access is no longer limited to reimbursement support or hub services; it is becoming a commercialization control layer spanning authorization, affordability, therapy i...

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provide insights across new biologics, and precision cancer therapy innovations. The research also comprises small molecule, cell and gene therapy and gene editing advancements for Niemann–Pick Disease and autoimmune diseases.The Life Science, Health & Wellness ...